50 patents currently held
69 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1 more record may belong here and awaits a decision; it is not counted.
The next term ends in Nov 2029. from the record
Of the 69 now held by other companies, 69 name Axora Medical Inc. as their current owner. Each row says so.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
7
Ending by 2030
Nov 2029
Next term end
15
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends May 2033 · High confidence
Also notable
Ends May 2034 · High confidence
Also notable
Ends Jun 2032 · High confidence
Tissue Extraction Devices and Methods
US 8,974,448
Cited by 79 later US patents, top 5% of utility patents granted in 2015 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2033.
Tissue Extraction Devices and Methods
US 9,439,720
Cited by 80 later US patents, top 5% of utility patents granted in 2016 in our data, and renewed at every maintenance window due so far. Protection runs to 2034.
Methods and Systems for Endometrial Ablation Utilizing Radio Frequency
US 9,289,257
Cited by 48 later US patents, top 10% of utility patents granted in 2016 in our data, and renewed at every maintenance window due so far. Protection runs to 2032.
Formerly held, still cited
Notable
Ends Oct 2031 · High confidence
Cited by 237 later US patents, top 5% of utility patents granted in 2013 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2031.
now held by Axora Medical, Inc.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Nov 23 to 30, 2026 · next Nov 23
- 1 fee due Apr 15, 2027The maintenance fee for Tissue Extraction Devices and Methods (US 10,441,353) comes due Apr 15, 2027. Unpaid by Oct 15, 2027, it lapses early.
- 1 fee due May 21, 2027The maintenance fee for Tissue Extraction Devices and Methods (US 11,819,263) comes due May 21, 2027. Unpaid by Nov 22, 2027, it lapses early.
- 1 fee due Jun 10, 2027The maintenance fee for Tissue Cutting Systems and Methods (US 10,499,987) comes due Jun 10, 2027. Unpaid by Dec 10, 2027, it lapses early.
- 3 fees due Jul 2 to 21, 2027 · next Jul 2
- 3 fees due Sep 22 to 30, 2027 · next Sep 22
- 2 fees due Oct 16, 2027
Recent changes
- 2 of the patents on this record were granted since Aug 18, 2026
What they patent
The 5 largest of its 15 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Tissue Extraction Devices and Methods (2012) | 7 in force | to May 2033 |
| Tissue Extraction Devices and Methods (2012) | 6 in force | to May 2034 |
| Methods and Systems for Endometrial Ablation Utilizing Radio Frequency | 6 in force | to Jun 2032 |
| Medical Systems and Methods | 5 in force | to Jan 2036 |
| Medical Device and Methods | 5 in force | to Dec 2033 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,636,171 | Methods and Systems for Endometrial Ablation Utilizing Radio Frequency In force · High confidence | In force | High confidence | |
| US 10,105,176 | Methods and Systems for Endometrial Ablation Utilizing Radio Frequency In force · High confidence | In force | High confidence | |
| US 11,413,088 | Methods and Systems for Endometrial Ablation Utilizing Radio Frequency In force · High confidence | In force | High confidence | |
| US 11,857,248 | Methods and Systems for Endometrial Ablation Utilizing Radio Frequency In force · High confidence | In force | High confidence | |
| US 12,369,972 | Methods and Systems for Endometrial Ablation Utilizing Radio Frequency In force · High confidence | In force | High confidence | |
| US 8,343,078 | Methods for Evaluating the Integrity of a Uterine Cavity In force · High confidence | In force | High confidence | |
| US 8,394,037 | Systems and Devices for Evaluating the Integrity of a Uterine Cavity In force · High confidence | In force | High confidence | |
| US 9,775,542 | Apparatus for Evaluating the Integrity of a Uterine Cavity In force · Medium confidence | In force | Medium confidence | |
| US 8,715,278 | System for Endometrial Ablation Utilizing Radio Frequency In force · High confidence | In force | High confidence | |
| US 11,324,546 | Tissue Extraction Devices and Methods In force · Low confidence | In force | Low confidence |
Also on record, not counted in the 50: 69 patents in force now held by others · 2 patents ended · 15 applications pending · 13 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.